Establishment of a Bank of Biospecimens for Future Research on Age-related Cognitive Disorders
NCT00911690 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 102
Last updated 2016-11-04
Summary
This study is collecting tissue specimens (blood, urine and saliva) from up to 1000 patients, with and without cognitive disorders, to store in the Bio Bank for future research. The specimens could be used in future research projects that could help improve the accuracy of diagnosis of a disease, predict who might develop a disease, help monitor the disease, or improve the understanding of the disease. Patients are only being recruited from Beaumont Hospitals Geriatric Clinic.
Conditions
- Dementia
- Alzheimers Disease
Sponsors & Collaborators
-
William Beaumont Hospitals
lead OTHER
Principal Investigators
-
Khaled Imam, M.D. · Beaumont Hospitals
Eligibility
- Min Age
- 60 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-07-31
- Primary Completion
- 2016-03-31
- Completion
- 2016-03-31
Countries
- United States
Study Locations
More Related Trials
-
Screening and Evaluation of Patients With Signs and Symptoms of Alzheimer's Disease
NCT00955422 ·Status: COMPLETED
-
BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers
NCT05457998 ·Status: ENROLLING_BY_INVITATION
-
The Evaluation and Follow-up of Individuals With Memory Disorder
NCT00001480 ·Status: COMPLETED
-
A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease
NCT01561053 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment
NCT00149175 ·Status: COMPLETED
-
A Multicenter Study on the Diagnosis and Intervention of New Biomarkers on the Prodromal Stage of Alzheimer's Disease
NCT04137926 ·Status: UNKNOWN ·Phase: NA
-
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
NCT05245903 ·Status: RECRUITING
-
Brain Imaging and Mental Disorders of Aging Intervention
NCT00267163 ·Status: COMPLETED ·Phase: PHASE4
-
Exploratory Clinical Study and Validation of Blood Biomarkers for Alzheimer's Disease
NCT07294586 ·Status: COMPLETED
-
Implications of Amyloid Pathology
NCT00900770 ·Status: UNKNOWN
-
Blood Gene Expression Signature in Patients Diagnosed With Probable Alzheimer's Disease Compared to Patients Suffering From Other Types of Dementia
NCT00880347 ·Status: COMPLETED ·Phase: NA
-
Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases
NCT02288000 ·Status: TERMINATED ·Phase: PHASE1
-
Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease
NCT00551161 ·Status: COMPLETED ·Phase: PHASE4
-
Mitochondrial Function and Metabolomic Profile in Alzheimer's Disease and Related Dementias
NCT06880406 ·Status: RECRUITING ·Phase: NA
-
Evaluation of [123I] AV51 and SPECT as a Marker of Beta-amyloid Protein Deposition in Subjects With Alzheimer Disease in Comparison to Healthy Subjects
NCT00556660 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
NCT07222280 ·Status: RECRUITING ·Phase: NA
-
A Community-Based Screening Program to Identify Participants at High Risk for Amyloid Pathology
NCT06043700 ·Status: ACTIVE_NOT_RECRUITING
-
Cognitive Neurology Unit Clinical Registry
NCT05925621 ·Status: RECRUITING
-
Memory and Mental Health in Aging
NCT00043589 ·Status: COMPLETED ·Phase: NA
-
Multi-parameter Diagnostic Blood Test for the Diagnosis of Alzheimer's Disease
NCT02409030 ·Status: COMPLETED
-
CPC-201 Alzheimer's Disease Type Dementia: PET Study
NCT02860065 ·Status: WITHDRAWN ·Phase: PHASE2
-
Clinical Evaluation of Blood-Based Assays for Rapid Detection of Aβ Pathology in Alzheimer's Disease
NCT06889896 ·Status: ENROLLING_BY_INVITATION
-
Biomarker Predictors of Memantine Sensitivity in Patients With Alzheimer's Disease
NCT03703856 ·Status: COMPLETED ·Phase: PHASE4
-
Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals
NCT00855868 ·Status: COMPLETED ·Phase: PHASE2
-
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
NCT07177352 ·Status: RECRUITING ·Phase: PHASE3